Efficacy and Tolerability of Enstilar® in Daily Practice

Exclusion Criteria

• •Enrolled in any interventional clinical trial
• •Ongoing or recent treatment with any systemic psoriasis
• •Ongoing or recent treatment with UV-therapy
• •Ongoing or previous treatment with Enstilar®
• •Psoriasis of scalp only
• •Other forms of psoriasis, e.g. erythrodermic or pustular psoriasis
• •More than 30% of surface area affected by psoriasis
• •Any contraindications or known allergies to Enstilar® or its ingredients
• •Incapacitated patients under institutionalized care